FDA asked to review hypertension drug
Gilead Sciences Inc. said Monday it has submitted a new drug application to the U.S. Food and Drug Administration for a drug to treat pulmonary arterial hypertension.
 |
 |
 |
 |
FDA asked to review hypertension drug
Gilead Sciences Inc. said Monday it has submitted a new drug application to the U.S. Food and Drug Administration for a drug to treat pulmonary arterial hypertension.
|
|
|
|